NCT06640010View on ClinicalTrials.gov

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

RecruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

January 13, 2025

Primary Completion Date

December 15, 2025

Study Completion Date

December 15, 2026

Conditions

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Interventions

OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (1)

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT06640010 - Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events | Biotech Hunter | Biotech Hunter